Evidence map›Paper›PMID 31341054›Full record

ArticleJournal of virology2019

Interferon-Inducible MicroRNA miR-128 Modulates HIV-1 Replication by Targeting TNPO3 mRNA.

Aurore Bochnakian, Anjie Zhen, Dimitrios G Zisoulis, Adam Idica, Vineet N KewalRamani, Nicholas Neel, Iben Daugaard, Matthias Hamdorf, Scott Kitchen, KyeongEun Lee and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Transportin-3 Facilitates Uncoating of Influenza A Virus.International journal of molecular sciences · 2022
    Article
  9. MicroRNA-1: Diverse role of a small player in multiple cancers.Seminars in cell & developmental biology · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Aurore BochnakianDepartment of Molecular Biology and Biochemistry, Francisco J. Ayala School of Biological Sciences, University of California-Irvine, Irvine, California, USA.
Anjie ZhenUCLA AIDS Institute, Los Angeles, California, USA.
Dimitrios G ZisoulisDepartment of Molecular Biology and Biochemistry, Francisco J. Ayala School of Biological Sciences, University of California-Irvine, Irvine, California, USA.
Adam IdicaDepartment of Molecular Biology and Biochemistry, Francisco J. Ayala School of Biological Sciences, University of California-Irvine, Irvine, California, USA.
Vineet N KewalRamaniBasic Research Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Nicholas NeelUCLA AIDS Institute, Los Angeles, California, USA.
Iben DaugaardDepartment of Molecular Biology and Biochemistry, Francisco J. Ayala School of Biological Sciences, University of California-Irvine, Irvine, California, USA.
Matthias HamdorfDepartment of Molecular Biology and Biochemistry, Francisco J. Ayala School of Biological Sciences, University of California-Irvine, Irvine, California, USA.
Scott KitchenUCLA AIDS Institute, Los Angeles, California, USA.
KyeongEun LeeBasic Research Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Irene Munk PedersenDepartment of Molecular Biology and Biochemistry, Francisco J. Ayala School of Biological Sciences, University of California-Irvine, Irvine, California, USA imp@uci.edu.
University of California, Irvine · USBlack AIDS Institute · USCenter for Cancer Research · USNational Cancer Institute · US

Funding

The role of CPSF6 in HIV-1 infectionZIABC010487 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEWALRAMANI, VINEET N · 2009 to 2025
$13.0M
miR regulation of the neurovasculature function in health and diseaseR01NS107344 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEDERSEN, IRENE MUNK · 2018 to 2021
$1.7M
NINDS NIH HHS R01 NS107344
6 · The paper itself

Abstract

The HIV/AIDS pandemic remains an important threat to human health. We have recently demonstrated that a novel microRNA (miR), miR-128, represses retrotransposon long interspaced element 1 (L1) by a dual mechanism, namely, by directly targeting the coding region of the L1 RNA and by repressing a required nuclear import factor (TNPO1). We have further determined that miR-128 represses the expression of all three TNPO proteins (transportins TNPO1, TNPO2, and TNPO3). Here, we establish that miR-128 also influences HIV-1 replication by repressing TNPO3, a factor that regulates HIV-1 nuclear import and viral; replication of TNPO3 is well established to regulate HIV-1 nuclear import and viral replication. Here, we report that type I interferon (IFN)-inducible miR-128 directly targets two sites in the TNPO3 mRNA, significantly downregulating TNPO3 mRNA and protein expression levels. Challenging miR-modulated Jurkat cells or primary CD4

Indexed as

Virus Replication3' Untranslated Regionsbeta KaryopherinsCell LineGene Expression RegulationHIV-1HIV InfectionsHost-Pathogen InteractionsHumansInterferonsMicroRNAsModels, BiologicalRNA Interference3' Untranslated Regionsbeta KaryopherinsInterferonsMicroRNAsMIRN128 microRNA, humanTNPO3 protein, humanHIV-1interferonsmiR-128miRNAnuclear import/exportrestriction factorTNPO3

Identifiers

PMID31341054
PMCPMC6798100
OpenAlexW2963035817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.